Modern techniques that enable the molecular characterisation of cancerous tissue have lead to the development of new and more specific therapies. Trastuzumab (Herceptin), a monoclonal antibody drug for the treatment of breast cancer, is one such therapy. Now that trastuzumab is approved for use in the UK, this article will discuss the nursing management of its infusion, possible side effects, aftercare and the psychological needs of the patient being treated with this new drug.
Cancer Nursing Practice. 3, 1, 35-39. doi: 10.7748/cnp2004.02.3.1.35.c108
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more